Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate

K. M. Sekins, J. J. Coalson, R. A. Delemos, T. K. Fields, S. F. Flaim, J. M. Guerra, R. M. Hopkins, J. C. Jackson, Donald Null, D. C. Winter

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose The feasibility and safety of continuous longterm (4-5 day) partial liquid ventilation (PLV) using perflubron was demonstrated in newborn baboons. PLV, a potential therapy for adult and neonatal respiratory distress syndrome (RDS), is conventional mechanical ventilation (CMV) with the lung filled to about functional residual capacity with perfluorochemical liquid.Protocol: As a pilot trial for a larger preclinical study focused on the safety of extended duration PLV, three near term baboons were studied. The animals were delivered by cesarean section, anesthetized, intubated and placed on CMV. The animals were given intratracheal perflubron (30 ml/kg) and maintained on PLV for 96 hours. The transition back to gas ventilation occurred, after draining, over the fifth day (hrs 96-120).Results: Two of the animals were born with normal pulmonary function, while the third developed respiratory distress prior to PLV. All the animals were adequately supported with PLV using moderate ventilator settings and low concentrations of oxygen. Perflubron distribution was enhanced by periodic rotation of the animals. Preliminary histology show vacuolated alveolar macrophages and no evidence of edema or other significant changes in the lungs. Pulmonary function in the RDS animal, after PLV treatment, showed normal gas exchange and lung mechanics. Conclusions: Three near term baboons, one with clinical RDS, tolerated 4 days of PLV followed by 1 day of CMV without complications using practical clinical management methods.

Original languageEnglish (US)
Pages (from-to)1381-1387
Number of pages7
JournalArtificial Cells, Blood Substitutes, and Biotechnology
Volume22
Issue number4
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Liquid Ventilation
Papio
Liquids
Animals
Lung
Artificial Respiration
Gases
Newborn Respiratory Distress Syndrome
Safety
Functional Residual Capacity
perflubron
Adult Respiratory Distress Syndrome
Alveolar Macrophages
Histology
Mechanical Ventilators
Mechanics
Cesarean Section
Ventilation
Edema
Oxygen

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering

Cite this

Sekins, K. M., Coalson, J. J., Delemos, R. A., Fields, T. K., Flaim, S. F., Guerra, J. M., ... Winter, D. C. (1994). Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate. Artificial Cells, Blood Substitutes, and Biotechnology, 22(4), 1381-1387. https://doi.org/10.3109/10731199409138841

Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate. / Sekins, K. M.; Coalson, J. J.; Delemos, R. A.; Fields, T. K.; Flaim, S. F.; Guerra, J. M.; Hopkins, R. M.; Jackson, J. C.; Null, Donald; Winter, D. C.

In: Artificial Cells, Blood Substitutes, and Biotechnology, Vol. 22, No. 4, 01.01.1994, p. 1381-1387.

Research output: Contribution to journalArticle

Sekins, KM, Coalson, JJ, Delemos, RA, Fields, TK, Flaim, SF, Guerra, JM, Hopkins, RM, Jackson, JC, Null, D & Winter, DC 1994, 'Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate', Artificial Cells, Blood Substitutes, and Biotechnology, vol. 22, no. 4, pp. 1381-1387. https://doi.org/10.3109/10731199409138841
Sekins, K. M. ; Coalson, J. J. ; Delemos, R. A. ; Fields, T. K. ; Flaim, S. F. ; Guerra, J. M. ; Hopkins, R. M. ; Jackson, J. C. ; Null, Donald ; Winter, D. C. / Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate. In: Artificial Cells, Blood Substitutes, and Biotechnology. 1994 ; Vol. 22, No. 4. pp. 1381-1387.
@article{2a1d7d502c6f4b869a5236ea25b22273,
title = "Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate",
abstract = "Purpose The feasibility and safety of continuous longterm (4-5 day) partial liquid ventilation (PLV) using perflubron was demonstrated in newborn baboons. PLV, a potential therapy for adult and neonatal respiratory distress syndrome (RDS), is conventional mechanical ventilation (CMV) with the lung filled to about functional residual capacity with perfluorochemical liquid.Protocol: As a pilot trial for a larger preclinical study focused on the safety of extended duration PLV, three near term baboons were studied. The animals were delivered by cesarean section, anesthetized, intubated and placed on CMV. The animals were given intratracheal perflubron (30 ml/kg) and maintained on PLV for 96 hours. The transition back to gas ventilation occurred, after draining, over the fifth day (hrs 96-120).Results: Two of the animals were born with normal pulmonary function, while the third developed respiratory distress prior to PLV. All the animals were adequately supported with PLV using moderate ventilator settings and low concentrations of oxygen. Perflubron distribution was enhanced by periodic rotation of the animals. Preliminary histology show vacuolated alveolar macrophages and no evidence of edema or other significant changes in the lungs. Pulmonary function in the RDS animal, after PLV treatment, showed normal gas exchange and lung mechanics. Conclusions: Three near term baboons, one with clinical RDS, tolerated 4 days of PLV followed by 1 day of CMV without complications using practical clinical management methods.",
author = "Sekins, {K. M.} and Coalson, {J. J.} and Delemos, {R. A.} and Fields, {T. K.} and Flaim, {S. F.} and Guerra, {J. M.} and Hopkins, {R. M.} and Jackson, {J. C.} and Donald Null and Winter, {D. C.}",
year = "1994",
month = "1",
day = "1",
doi = "10.3109/10731199409138841",
language = "English (US)",
volume = "22",
pages = "1381--1387",
journal = "Artificial Cells, Nanomedicine and Biotechnology",
issn = "2169-1401",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonate

AU - Sekins, K. M.

AU - Coalson, J. J.

AU - Delemos, R. A.

AU - Fields, T. K.

AU - Flaim, S. F.

AU - Guerra, J. M.

AU - Hopkins, R. M.

AU - Jackson, J. C.

AU - Null, Donald

AU - Winter, D. C.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Purpose The feasibility and safety of continuous longterm (4-5 day) partial liquid ventilation (PLV) using perflubron was demonstrated in newborn baboons. PLV, a potential therapy for adult and neonatal respiratory distress syndrome (RDS), is conventional mechanical ventilation (CMV) with the lung filled to about functional residual capacity with perfluorochemical liquid.Protocol: As a pilot trial for a larger preclinical study focused on the safety of extended duration PLV, three near term baboons were studied. The animals were delivered by cesarean section, anesthetized, intubated and placed on CMV. The animals were given intratracheal perflubron (30 ml/kg) and maintained on PLV for 96 hours. The transition back to gas ventilation occurred, after draining, over the fifth day (hrs 96-120).Results: Two of the animals were born with normal pulmonary function, while the third developed respiratory distress prior to PLV. All the animals were adequately supported with PLV using moderate ventilator settings and low concentrations of oxygen. Perflubron distribution was enhanced by periodic rotation of the animals. Preliminary histology show vacuolated alveolar macrophages and no evidence of edema or other significant changes in the lungs. Pulmonary function in the RDS animal, after PLV treatment, showed normal gas exchange and lung mechanics. Conclusions: Three near term baboons, one with clinical RDS, tolerated 4 days of PLV followed by 1 day of CMV without complications using practical clinical management methods.

AB - Purpose The feasibility and safety of continuous longterm (4-5 day) partial liquid ventilation (PLV) using perflubron was demonstrated in newborn baboons. PLV, a potential therapy for adult and neonatal respiratory distress syndrome (RDS), is conventional mechanical ventilation (CMV) with the lung filled to about functional residual capacity with perfluorochemical liquid.Protocol: As a pilot trial for a larger preclinical study focused on the safety of extended duration PLV, three near term baboons were studied. The animals were delivered by cesarean section, anesthetized, intubated and placed on CMV. The animals were given intratracheal perflubron (30 ml/kg) and maintained on PLV for 96 hours. The transition back to gas ventilation occurred, after draining, over the fifth day (hrs 96-120).Results: Two of the animals were born with normal pulmonary function, while the third developed respiratory distress prior to PLV. All the animals were adequately supported with PLV using moderate ventilator settings and low concentrations of oxygen. Perflubron distribution was enhanced by periodic rotation of the animals. Preliminary histology show vacuolated alveolar macrophages and no evidence of edema or other significant changes in the lungs. Pulmonary function in the RDS animal, after PLV treatment, showed normal gas exchange and lung mechanics. Conclusions: Three near term baboons, one with clinical RDS, tolerated 4 days of PLV followed by 1 day of CMV without complications using practical clinical management methods.

UR - http://www.scopus.com/inward/record.url?scp=0027931480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027931480&partnerID=8YFLogxK

U2 - 10.3109/10731199409138841

DO - 10.3109/10731199409138841

M3 - Article

VL - 22

SP - 1381

EP - 1387

JO - Artificial Cells, Nanomedicine and Biotechnology

JF - Artificial Cells, Nanomedicine and Biotechnology

SN - 2169-1401

IS - 4

ER -